These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35384032)

  • 1. Will people in conflict affected zones in Africa have access to COVID-19 vaccine? A case of Nigeria.
    Oladunni AA; Haruna UA; Ijafu LG; Lucero-Prisno DE
    Int J Health Plann Manage; 2022 Jul; 37(4):1918-1925. PubMed ID: 35384032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to Vaccination Among Populations in Areas of Conflict.
    Nnadi C; Etsano A; Uba B; Ohuabunwo C; Melton M; Wa Nganda G; Esapa L; Bolu O; Mahoney F; Vertefeuille J; Wiesen E; Durry E
    J Infect Dis; 2017 Jul; 216(suppl_1):S368-S372. PubMed ID: 28838202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supporting the pandemic response and timely access to COVID-19 vaccines: a case for stronger priority setting and health system governance in Nigeria.
    Chukwu OA; Kapiriri L; Essue B
    Int J Pharm Pract; 2022 Jun; 30(3):284-287. PubMed ID: 35468198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccine hesitancy among Nigerians living with non-communicable diseases: a qualitative study.
    Ojewale LY; Mukumbang FC
    BMJ Open; 2023 Feb; 13(2):e065901. PubMed ID: 36731928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Perception, Reasons, and Motivations for COVID-19 Vaccination in People with Diabetes across Sub-Saharan Africa: A Mixed-Method Approach.
    Osuagwu UL; Langsi R; Ovenseri-Ogbomo G; Mashige KP; Abu EK; Envuladu EA; Goson PC; Ekpenyong BN; Oloruntoba R; Miner CA; Charwe DD; Timothy CG; Ishaya T; Amiebenomo OM; Lim D; Agho KE
    Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccine hesitancy in Africa: a scoping review.
    Ackah BBB; Woo M; Stallwood L; Fazal ZA; Okpani A; Ukah UV; Adu PA
    Glob Health Res Policy; 2022 Jul; 7(1):21. PubMed ID: 35850783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 outbreak: a potential threat to routine vaccination programme activities in Nigeria.
    Ogundele OA; Omotoso AA; Fagbemi AT
    Hum Vaccin Immunother; 2021 Mar; 17(3):661-663. PubMed ID: 32991237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the boundaries of vaccine discourse: impact of visual illustrations communication intervention on intention towards COVID-19 vaccination among victims of insecurity in Nigeria.
    Ugwuoke JC; Talabi FO; Adelabu O; Sanusi BO; Gever VC; Onuora C
    Hum Vaccin Immunother; 2021 Oct; 17(10):3450-3456. PubMed ID: 34128754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions.
    Tagoe ET; Sheikh N; Morton A; Nonvignon J; Sarker AR; Williams L; Megiddo I
    Front Public Health; 2021; 9():709127. PubMed ID: 34422750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to COVID-19 vaccines and testing in Africa: the importance of COVAX - Nigeria as a case study.
    Grenfell RFQ; Oyeyemi OT
    Pathog Glob Health; 2023 Mar; 117(2):152-166. PubMed ID: 35770309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of Conflict on Immunisation Coverage in 16 Countries.
    Grundy J; Biggs BA
    Int J Health Policy Manag; 2019 Apr; 8(4):211-221. PubMed ID: 31050966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stakeholders' hopes and concerns about the COVID-19 vaccines in Southeastern Nigeria: a qualitative study.
    Chukwuocha UM; Emerole CO; Iwuoha GN; Dozie UW; Njoku PU; Akanazu CO; Eteike PO; Hemingway C
    BMC Public Health; 2022 Feb; 22(1):330. PubMed ID: 35172789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of integrated supportive supervision in the context of coronavirus 19 pandemic: its effects on routine immunization and vaccine preventable surveillance diseases indicators in the East and Southern African countries.
    Bello IM; Lebo E; Shibeshi ME; Akpan GU; Chakauya J; Masresha BG; Daniel F
    Pan Afr Med J; 2021; 38():164. PubMed ID: 33995771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study.
    Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H
    BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress with COVID-19 vaccination in the WHO African Region in 2021.
    Masresha B; Poy A; Weldegebriel G; Mbuyita S; Fussum D; Bwaka A; Paluku G; Atuhebwe P; Mihigo R; Impouma B
    Pan Afr Med J; 2022; 41(Suppl 2):8. PubMed ID: 36159031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccination in Nigeria: A rapid review of vaccine acceptance rate and the associated factors.
    Olu-Abiodun O; Abiodun O; Okafor N
    PLoS One; 2022; 17(5):e0267691. PubMed ID: 35544545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19 vaccine hesitancy in six geopolitical zones in Nigeria: a cross-sectional survey.
    Ogunbosi BO; Alao MA; Ibrahim OR; Ayuk AC; Ibraheem RM; Odimegwu CL; Ikwuka DC; Akintan P; Morakinyo O; Adeyemi AT; Jega RM; Olowookere TF; Bello OE; Owolabi BI; Chukwuyem A; Bukar LM; Rasaki A; Issa A; Ewa AU; Oladokun R; Akinyinka OO
    Pan Afr Med J; 2022; 42():179. PubMed ID: 36187029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Events Following COVID-19 Vaccination in Rivers State, Nigeria: A Cross-Sectional Study.
    Harry AM; Edet CK; Ekanem NE; Kemdirim CJ; Uduak AE
    Niger Postgrad Med J; 2022; 29(2):89-95. PubMed ID: 35488575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low coverage of COVID-19 vaccines in Africa: current evidence and the way forward.
    Lawal L; Aminu Bello M; Murwira T; Avoka C; Yusuf Ma'aruf S; Harrison Omonhinmin I; Maluleke P; Tsagkaris C; Onyeaka H
    Hum Vaccin Immunother; 2022 Dec; 18(1):2034457. PubMed ID: 35240908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Vaccine Diplomacy and Equitable Access to Vaccines Amid Ongoing Pandemic.
    Sharun K; Dhama K
    Arch Med Res; 2021 Oct; 52(7):761-763. PubMed ID: 33941393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.